In the latest episode of the CReATe ALS Untangled podcast series, Dr. Xiaoyan Li and Ron Faretra review pyridostigmine (Mestinon®), a medication commonly used to treat myasthenia gravis that has been proposed as a potential treatment for ALS. They discuss how pyridostigmine works at the neuromuscular junction, examine the available scientific evidence, review potential risks and side effects, and evaluate whether it may have a role in slowing ALS progression. Their discussion helps people living with ALS make informed decisions about this treatment option.
Image
Listen to Our Latest ALS Untangled Series Podcast
September 3 2026